Promisia Healthcare (PHL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
15 Jun, 2026Executive summary
Achieved a 37% year-over-year increase in operating revenue to $31.08 million, driven by acquisitions and higher occupancy.
Net profit after tax surged 318% to $6.8 million, reflecting operational improvements and acquisition gains.
Completed acquisitions of Golden View Lifestyle Village and Ripponburn Home and Hospital, and sold Eileen Mary facility.
Successfully executed a $4.7 million capital raise and consolidated all interest-bearing debt under BNZ.
Financial highlights
Underlying EBITDAF rose 11.5% to $4.2 million, in line with market guidance.
Total assets increased 104% to $172 million.
Net tangible assets per share climbed 25% year-over-year to 79 cents.
Operating expenses increased to $23.9 million due to scale and integration costs.
Valuations of care facilities and villages increased by $3.7 million.
Outlook and guidance
Underlying EBITDAF is anticipated to grow in excess of 25% in FY26.
Continued focus on operational enhancement and sustainable expansion.
Occupancy expected to benefit from the opening of a new 20-bed dementia wing.
Latest events from Promisia Healthcare
- EBITDAF up 31%, revenue up 47%, and occupancy at 90% with upgraded full-year guidance.PHL
H1 202615 Jun 2026 - Record revenue and profit growth driven by acquisitions and operational improvements.PHL
H1 202515 Jun 2026 - Revenue up 29%, EBITDAF up 58%, and new dividend policy based on free cash flow for FY27.PHL
H2 202627 May 2026 - Revenue up 37% and EBITDAF up 11.5%, with strong growth and expansion plans underway.PHL
AGM 2025 Presentation15 May 2026 - Promisia Healthcare targets double-digit earnings growth after a year of strong operational gains.PHL
AGM 2024 Presentation13 Jun 2025 - Cromwell acquisition and capital raise position Promisia for accelerated earnings growth.PHL
Investor Presentation13 Jun 2025